Showing 1 - 3 results of 3 for search 'Lara Moumné', query time: 0.02s Refine Results
  1. 1
    Oligonucleotide Therapeutics: From Discovery and Development to Patentability

    Oligonucleotide Therapeutics: From Discovery and Development to Patentability by Lara Moumné, Anne-Céline Marie, Nicolas Crouvezier

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease.

    Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease. by Lara Moumné, Ken Campbell, David Howland, Yingbin Ouyang, Gillian P Bates

    Published 2012-01-01
    Get full text
    Article
  3. 3
    Oral administration of the pimelic diphenylamide HDAC inhibitor HDACi 4b is unsuitable for chronic inhibition of HDAC activity in the CNS in vivo.

    Oral administration of the pimelic diphenylamide HDAC inhibitor HDACi 4b is unsuitable for chronic inhibition of HDAC activity in the CNS in vivo. by Maria Beconi, Omar Aziz, Kim Matthews, Lara Moumné, Catherine O'Connell, Dawn Yates, Steven Clifton, Hannah Pett, Julie Vann, Lynsey Crowley, Alan F Haughan, Donna L Smith, Ben Woodman, Gillian P Bates, Fred Brookfield, Roland W Bürli, George McAllister, Celia Dominguez, Ignacio Munoz-Sanjuan, Vahri Beaumont

    Published 2012-01-01
    Get full text
    Article

Search Tools: